---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-008169"
form_type: "8-K"
ticker: "CBDW"
cik: "0001877461"
company_name: "1606 CORP."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T02:06:09.288948+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# 1606 Corp. supports Adnexus AI health tech; LOI terminated but still pursuing deal

## Summary
- 1606 Corp. issued press release supporting Adnexus Biotechnologies' Neural Temporal Fingerprinting AI technology for personalized health monitoring using EEG/ECG.
- Adnexus' technology targets early detection of Alzheimer's, Parkinson's, PTSD, and cardiovascular risks via AI analysis of EEG/ECG signals.
- Previously signed LOI for strategic investment by 1606 in Adnexus terminated on Nov 28, 2024, but parties still working to close the deal.
- CEO Austen Lambrecht sees transformative potential in AI-driven health diagnostics and wearable integration for both companies.

## SEC filing metadata
- accession: 0001477932-24-008169
- form_type: 8-K
- ticker: CBDW
- cik: 0001877461
- company_name: 1606 CORP.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877461/000147793224008169/0001477932-24-008169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877461/000147793224008169/onesix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-008169
- JSON: https://secwatch.observer/filing/0001477932-24-008169.json
- Plain text: https://secwatch.observer/filing/0001477932-24-008169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.